
What smart money is saying about NRC
2 funds in our archive have pitched NRC — most recently Long Cast Advisers Small- & Micro-Cap Concentrated Strategy in June 2026.
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
Get an email when a fund writes about it
Position history
Between Q4 2025 and Q2 2026, 1 fund letter reported a position in NRC — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | 0 | 1 |
| Q4 2025 | 0 | 0 | 0 | 1 |
Fund activity · 1 position · 1 move
- AddedLong Cast Advisers Small- & Micro-Cap Concentrated StrategyJune 2026
“On NRC, our newest investment, I discussed the company’s evolution from owner / operator to professionally led management team”
Read the letterNRC
Fund coverage · 2 theses
- Long Cast Advisers Small- & Micro-Cap Concentrated StrategyJune 2026
NRC combines a stronger management team, strong free cash flow, record backlog, and potential growth from a larger second-year contract.
Read the full thesis - Long Cast AdvisersDecember 2025
National Research Corporation is an owner-operated healthcare survey and consulting firm with high margins, new leadership, improving deferred revenue, and supportive industry consolidation signals.
Read the full thesis
Read every full thesis on NRC
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→